Vol. 27, No.1
January 2004
Assessing Ventricular Function for Risk Stratification
C. R. Conti, M.D., M.A.C.C. 1
D. Brieger, MBBS., Ph.D., FRACP 3
A. Miyamoto, M.D., A. R. Prieto, M.D., FACC, S. E. Friedl, M.E.E., F. C. Lin, Ph.D., J. E. Muller, M.D., FACC, R. W. Nesto, M.D., FACC, G. S. Abela, M.Sc, M.D., FACC 9
S. M. Kent, M.D., L. C. Coyle, D.O., P. J. Flaherty, D.O., T. T. Markwood, M.D., A. J. Taylor, M.D. 17
A. López-Candales, M.D., FACC, C. Carron, FNP, J. Schwartz, M.D., FACC 23
J.-K. Song, M.D., J.-M. Song, M.D., D.-H. Kang, M.D., B. Haluska, R.D.C.S., T. H. Marwick, M.B.B.S. 29
H. Yamada, M.D., Ph.D., T. Oki, M.D., Ph.D., T. Yamamoto, M.D., Ph.D., H. Tanaka, M.D., T. Tabata, M.D., Ph.D., FACC, T. Wakatsuki, M.D., Ph.D., M. Nomura, M.D., Ph.D., S. Ito, M.D., Ph.D., J. D. Thomas, M.D., FACC 33
C. Stöllberger, M.D., P. Chnupa, M.D., C. Abzieher, M.D., Dipl. Ing. T. Länger, J. Finsterer, M.D., I. Klem, M.D., E. Hartl, M.D., C. Wehinger, M.D., B. Schneider, Ph.D. 40
Effect of Bachmann's Bundle Pacing on Atrial Fibrillation: Electrophysiologic Assessment
H. Noguchi, M.D., K. Kumagai, M.D., FACC, H. Tojo, M.D.,T. Yasuda, M.D., K. Saku, M.D., FACC 50
Endomyocardial Fibrosis in Churg-Strauss Syndrome
B. Mukherjee, MB, B. Chir, J. C. C. Moon, MRCP, M. Sandrasagra, MRCP, D. J. Pennell, FRCP 21
Two Large Thrombi in the Left Atrium in an Elderly Patient with Mitral Valve Stenosis
C. Aggeli, M.D., C. Mauronasios, M.D., C. Theocharis, M.D., M. Bonou, M.D., C. Stefanadis, M.D., P. Toutouzas, M.D. 39
The Imaging Spectrum of Apical Hypertrophic Cardiomyopathy
M. Valderrábano, M.D., and R. J. Siegel, M.D. 49
TBRAVE (Bavarian Reperfusion
Alternatives Evaluation Trial) 54
ACTIV in CHF (Acute and Chronic
Therapeutic Impact of a Vasopressin 2 Antagonist [Tolvaptan] in Congestive Heart
Failure) 54
DIABETES (Diabetes and Sirolimus-Eluting
Stent Trial) 54
SPORTIF V (Stroke Prevention
Using an Oral Thrombin Inhibitor [Ximelagatran] in Atrial Fibrillation) 55
CREST (Cilostazol for Restenosis
Trial) 55
PRIMO-CABG (Pexelizumab for the
Reduction in Infarction and Mortality in Coronary Artery Bypass Graft Surgery)
56
VALIANT (Valsartan in Acute Myocardial
Infarction) 56
WITTI (Secondary Prevention Beyond
Walls Intervention Trial in Women Study) 57
J.K. Kahn, M.D. 58
Continuing Medical Education
Articles in Brief A19
Calendar A25